Thoratec Presentation At Bank of America Merrill Lynch 2013 Health Care
Conference To Be Webcast
PLEASANTON, Calif., May 14, 2013
PLEASANTON, Calif., May 14, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ:
THOR), a world leader in device-based mechanical circulatory support therapies
to save, support and restore failing hearts, said today it will be
participating in the Bank of America Merrill Lynch 2013 Health Care Conference
on Thursday, May 16.
Taylor C. Harris, Vice President and Chief Financial Officer, will provide an
update on the company, beginning at 10:40 a.m., Pacific Daylight Time (1:40
p.m., Eastern Daylight Time).
The presentation will be available through the conference web site at
http://www.veracast.com/webcasts/baml/healthcare2013/id36712670.cfm, or on the
company's web site at http://www.thoratec.com.
Thoratec is a world leader in therapies to address advanced-stage heart
failure. The company's products include the HeartMate® LVAS (Left Ventricular
Assist System) and Thoratec® VAD (Ventricular Assist Device) with more than
20,000 devices implanted in patients suffering from heart failure. Thoratec
also manufactures and distributes the CentriMag® and PediMag®/PediVAS® product
lines. Thoratec is headquartered in Pleasanton, California. For more
information, visit the company's web site at http://www.thoratec.com.
Thoratec, the Thoratec logo, HeartMate, HeartMate II and GoGear are registered
trademarks of Thoratec Corporation. CentriMag and PediMag are registered
trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec
SOURCE Thoratec Corporation
Contact: Taylor Harris, Vice President and Chief Financial Officer, Thoratec
Corporation, (925) 738-0047
Press spacebar to pause and continue. Press esc to stop.